Skip to main content

MoneyWorks4Me

Kilitch Drugs (India) informs about certificate

17 Jul 2023 Evaluate

Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Kilitch Drugs (India) has informed that it enclosed the Certificate received from Link Intime India, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th June, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1874.60
Dr. Reddys Labs. 1378.50
Cipla 1395.60
Lupin 1986.65
Zydus Lifesciences 1189.50
View more..